SCHEMBL31336022

SCHEMBL31336022

CCc1cc(C(=O)O)c(O)cc1OC

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HMGCR P04035 2/20 0.54
HTT P42858 2/20 0.50
KDM4E B2RXH2 3/20 0.45
MAPT P10636 3/20 0.45
HPGD P15428 2/20 0.45
LMNA P02545 1/20 0.45
CYP3A4 P08684 1/20 0.45
RECQL P46063 1/20 0.45
HSD17B10 Q99714 1/20 0.45
TAAR1 Q96RJ0 2/20 0.44
LCK P06239 1/20 0.44
FYN P06241 1/20 0.44
PTGS2 P35354 1/20 0.44
HSP90AA1 P07900 1/20 0.43
CA12 O43570 1/20 0.43
CA1 P00915 1/20 0.43
CA2 P00918 1/20 0.43
CA3 P07451 1/20 0.43
PKM P14618 1/20 0.43
CA4 P22748 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8902437 0.85 KDM4E (0.53) KDM4EMAPTHPGDCYP3A4HSD17B10
SCHEMBL9417898 0.85 ALDH1A1 (0.56) HMGCRHTTKDM4EMAPTHPGD
SCHEMBL31335728 0.84 HMGCR (0.53) HMGCRHTTKDM4ELMNARECQL
SCHEMBL19387546 0.83 HMGCR (0.45) HMGCRHTTKDM4EMAPTHPGD
SCHEMBL28252586 0.83 HTT (0.70) HMGCRHTTKDM4EMAPTHPGD
SCHEMBL1038769 0.83 HTT (0.70) HMGCRHTTKDM4EMAPTHPGD
SCHEMBL9417829 0.81 HMGCR (0.54) HMGCRHTTKDM4EMAPTHPGD
SCHEMBL10031634 0.81 MAPT (0.73) HMGCRHTTKDM4EMAPTHPGD
SCHEMBL20724883 0.81 HTT (0.57) HMGCRHTTKDM4EMAPTHPGD
SCHEMBL3836141 0.81 MAPT (0.64) HMGCRHTTKDM4EMAPTHPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4720038-A1 (HETERO)ARYL-CARBONYL-HETEROBICYCLIC COMPOUNDS AS INHIBITORS OF PMS2 FOR CANCER AND DEGENERATIVE ILLNESSES Neophore Limited (GB) 2026-04-08 EP disclosed
WO-2024246496-A1 (HETERO)ARYL-CARBONYL-HETEROBICYCLIC COMPOUNDS AS INHIBITORS OF PMS2 FOR CANCER AND DEGENERATIVE ILLNESSES Neophore Limited (GB) 2024-12-05 WO disclosed